Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Mismetti

Showing results (41-50 of 179) with videos related to

Pageof 18
Sort By:
International Journal of Molecular Sciences|August 7, 2021
Platelet Innate Immune Receptors and TLRs: A Double-Edged SwordThéo Ebermeyer, Fabrice Cognasse, Philippe Berthelot, et al.
Therapie|June 4, 2011
[Drug induced hyponatremia. About a series of 54 cases notified to the regional center of pharmacovigilance of Saint-Étienne]Ivan Fenoglio, Claire Guy, Marie-Noëlle Beyens, et al.
Clinical Pharmacokinetics|January 25, 2006
Compliance-guided therapy : a new insight into the potential role of clinical pharmacologistsAlexia Blesius, Sylvie Chabaud, Michel Cucherat, et al.
Journal of the American College of Cardiology|April 12, 2008
SR123781A: a new once-daily synthetic oligosaccharide anticoagulant for thromboprophylaxis after total hip replacement surgery: the DRIVE (Dose Ranging Study in Elective Total Hip Replacement Surgery) studyMichael R Lassen, Ola Dahl, Patrick Mismetti, et al.
Therapie|July 27, 2013
[Intracranial hemorrhages: epidemiology and implication of antithrombotic therapy]Jérôme Varvat, Magali Epinat, Christophe Nuti, et al.
Presse Medicale (Paris, France : 1983)|July 27, 2013
[Thromboprophylaxis in medical patients: Which modifications with the new oral anticoagulants?]Laurent Bertoletti, Jean-Christophe Lega, Sandrine Accassat, et al.
Arthroscopy : the Journal of Arthroscopic & Related Surgery : Official Publication of the Arthroscopy Association of North America and the International Arthroscopy Association|May 13, 2014
Prevention of venous thromboembolic events with low-molecular-weight heparin in the non-major orthopaedic setting: meta-analysis of randomized controlled trialsCéline Chapelle, Nadia Rosencher, Paul Jacques Zufferey, et al.
European Journal of Internal Medicine|February 25, 2009
INR variability in atrial fibrillation: a risk model for cerebrovascular eventsPhilippe Amouyel, Patrick Mismetti, Lars K Langkilde, et al.
Thrombosis and Haemostasis|September 30, 2003
Optimal low-molecular-weight heparin regimen in major orthopaedic surgery. A meta-analysis of randomised trialsPaul Zufferey, Silvy Laporte, Sara Quenet, et al.
International Journal of Pharmaceutics|September 22, 2018
Assessment of HBEC-5i endothelial cell line cultivated in astrocyte conditioned medium as a human blood-brain barrier model for ABC drug transport studiesClémentine Puech, Sophie Hodin, Valérie Forest, et al.
Pageof 18

Showing results (41-50 of 179) with videos related to

Sort By:
Pageof 18
International Journal of Molecular Sciences|August 7, 2021
Platelet Innate Immune Receptors and TLRs: A Double-Edged SwordThéo Ebermeyer, Fabrice Cognasse, Philippe Berthelot, et al.
Therapie|June 4, 2011
[Drug induced hyponatremia. About a series of 54 cases notified to the regional center of pharmacovigilance of Saint-Étienne]Ivan Fenoglio, Claire Guy, Marie-Noëlle Beyens, et al.
Clinical Pharmacokinetics|January 25, 2006
Compliance-guided therapy : a new insight into the potential role of clinical pharmacologistsAlexia Blesius, Sylvie Chabaud, Michel Cucherat, et al.
Journal of the American College of Cardiology|April 12, 2008
SR123781A: a new once-daily synthetic oligosaccharide anticoagulant for thromboprophylaxis after total hip replacement surgery: the DRIVE (Dose Ranging Study in Elective Total Hip Replacement Surgery) studyMichael R Lassen, Ola Dahl, Patrick Mismetti, et al.
Therapie|July 27, 2013
[Intracranial hemorrhages: epidemiology and implication of antithrombotic therapy]Jérôme Varvat, Magali Epinat, Christophe Nuti, et al.
Presse Medicale (Paris, France : 1983)|July 27, 2013
[Thromboprophylaxis in medical patients: Which modifications with the new oral anticoagulants?]Laurent Bertoletti, Jean-Christophe Lega, Sandrine Accassat, et al.
Arthroscopy : the Journal of Arthroscopic & Related Surgery : Official Publication of the Arthroscopy Association of North America and the International Arthroscopy Association|May 13, 2014
Prevention of venous thromboembolic events with low-molecular-weight heparin in the non-major orthopaedic setting: meta-analysis of randomized controlled trialsCéline Chapelle, Nadia Rosencher, Paul Jacques Zufferey, et al.
European Journal of Internal Medicine|February 25, 2009
INR variability in atrial fibrillation: a risk model for cerebrovascular eventsPhilippe Amouyel, Patrick Mismetti, Lars K Langkilde, et al.
Thrombosis and Haemostasis|September 30, 2003
Optimal low-molecular-weight heparin regimen in major orthopaedic surgery. A meta-analysis of randomised trialsPaul Zufferey, Silvy Laporte, Sara Quenet, et al.
International Journal of Pharmaceutics|September 22, 2018
Assessment of HBEC-5i endothelial cell line cultivated in astrocyte conditioned medium as a human blood-brain barrier model for ABC drug transport studiesClémentine Puech, Sophie Hodin, Valérie Forest, et al.
Pageof 18